HORIZON-EIC-2022-ACCELERATOROPEN-01
HORIZON-EIC-2022-ACCELERATOROPEN-01
Programme: Horizon Europe
145 projects · €337,320,410 total EU contribution (project-level) · 157 participating organizations · 23 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€337,320,410
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (25)
- France (24)
- Netherlands (21)
- Spain (12)
- BE (9)
- SE (9)
- IE (7)
- AT (6)
- FI (6)
- IL (6)
- Italy (5)
- NO (5)
- DK (4)
- IS (3)
- PT (3)
- BG (2)
- CZ (2)
- EE (2)
- LU (2)
- PL (1)
- RO (1)
- RS (1)
- SI (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- 3DEUS DYNAMICS SAS1 projects · FR
- ABZU APS1 projects · DK
- ABZU BARCELONA S.L.1 projects · ES
- ACTOME GMBH1 projects · DE
- ADJ1 projects · DE
- ABCDX1 projects · ES
- AI4MEDIMAGING MEDICAL SOLUTIONS SA1 projects · PT
- AKKNATEK GMBH1 projects · DE
- AkknaTek Lux1 projects · LU
- ALA DIAGNOSTICS SL1 projects · ES
- ALCYON PHOTONICS1 projects · ES
- ALOCALO1 projects · DE
Projects
Page 1 of 15
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
A Disruptively Novel Approach to Clean and Safe Water Supply to Off-Grid Communities – SAFEWater-SDCW SAFEWater-SDCW · 190157957 | HORIZON | €1,539,106 | €2,198,723 | Details |
APAC – the first targeted therapy for peripheral arterial occlusive disease. APAC-ON · 190168043 | HORIZON | €2,099,388 | €2,999,125 | Details |
RondelO - the first medical stopcock designed for sequential intraveneous infusion of incompatible drugs RondelO · 190103560 | HORIZON | €1,941,782 | €2,773,975 | Details |
Paragon Novel Vaccine (PNV) an effective protection against all serotypes of five deadly bacteria to eradicate Antimicrobial Resistance (AMR) PARAGON NOVEL VACCINE · 190152193 | HORIZON | €2,500,000 | €7,400,193 | Details |
Development and validation of the first digital, clinical grade flow cytometry platform for enhanced diagnosis accuracy and sustainability in immunology and hemato oncology METAflow · 190166506 | HORIZON | €2,499,579 | €3,570,828 | Details |
M80 - an hybrid-electric regional commercial aviation Aircraft Maeve 01 · 190132613 | HORIZON | €2,499,000 | €3,570,000 | Details |
Unlocking the Power of Medical Images for Surgeons AVATAR · 190147557 | HORIZON | €2,492,262 | €3,560,375 | Details |
Democratizing AI for cognitive process automation DeepOpinion · 190183999 | HORIZON | €1,950,095 | €2,785,850 | Details |
Adpative DBS alphadbs · 190186802 | HORIZON | €2,499,999 | €3,725,438 | Details |
Homeoproteins as novel therapies for neurodegenerative diseases HOMEOBRAIN · 190105256 | HORIZON | €2,500,000 | €5,523,750 | Details |